- Texas A&M University
- United States of America
About Rod Dashwood
Roderick H. Dashwood, Ph.D., FRSB | Director, Center for Epigenetics & Disease Prevention, Texas A&M Health, 2121 W. Holcombe Blvd., Houston, TX 77030; John S. Dunn Chair for Disease Prevention; Professor, Dept. Translational Medical Sciences, Texas A&M School of Medicine.
Subject
Popular Content
Details
-
Website
-
Email
-
Telephone+01-713-677-7806
Online Elsewhere
-
Twitter
-
ORCID
Experts Like Rod Dashwood
Recent Comments
Supplementary figures | Constitutive expression of ACE2 in human colon cancer cells; ACE2 regulates DNA repair, cell viability and apoptosis in SW480 and SW620 human colon cancer cells; forced expression of ACE2 increases endogenous BRD4 and c-Myc in SW480 cells; BET inhibitors and degraders lower endogenous ACE2 and c-Myc expression in human colon cancer cells; ACE2 overexpression in rat colon adenomas; gating strategies for cell sorting via FACS.
Current contact information:
Dr. Shilan Zhang,
Department of Cardiovascular Medicine,
Shanghai Tenth People's Hospital,
Tongji University School of Medicine.
Email: slzhang7@sina.com
Current contact information:
Dr. Chakrapani Tripathi, Senior Scientist
Nektar Therapeutic,
455 Mission Bay Boulevard South,
San Francisco, CA 94158.
Email: chakrapani010@gmail.com
ctripathi@nektar.com
Phone: 3179353701
Acknowledgements | Nivedhitha Mohan provided initial drafts of the text and associated artwork, and was a major contributor to the blog, along with further edits by other coauthors, in particular, Dr. Praveen Rajendran.